Skip to main content

Table 1 Prevalence of hypertension and percentage of hypertension awareness, treatment, and control in Khuzestan province: 2017 ACC/AHA guideline vs NCJ8 report

From: Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran

Determinants of hypertension Prevalence Awareness Treatment Control
2017 ACC/AHA JNC88 2017 ACC/AHA JNC8 2017 ACC/AHA JNC8 2017 ACC/AHA JNC8
Overall 42.85 15.81 22.72 45.85 26.37 35.42 28.94 59.63
Mean age (±SD) 45.72 (11.71) 50.4 (10.17) 53.45 (8.11) 53.75 (7.89) 54.36 (7.51) 54.36 (7.51) 51.91 (9.72) 53.06 (8.84)
Age group
 <25 24.44 3.36 1.94 7.04 20.0 40.00 66.67 83.33
 25–34 28.53 4.81 3.18 12.13 17.14 26.67 66.67 83.33
 35–44 36.95 9.95 11.45 29.23 20.65 30.04 36.84 67.37
 45–54 52.73 22.28 27.49 48.54 25.10 33.65 29.31 57.93
 55–64 65.32 35.52 41.20 57.68 29.25 38.43 25.26 58.32
 =65 75.45 45.51 53.17 68.42 22.39 28.85 13.33 40.00
Gender
 Male 50.30 17.79 14.90 31.06 24.91 33.78 26.51 54.62
 Female 38.70 14.70 28.38 55.81 26.92 36.03 29.85 61.49
Marital status
 Single 31.02 5.75 4.61 16.27 23.08 35.29 50.00 75.00
 Married 43.89 16.56 23.16 45.68 26.02 34.96 29.17 59.62
 Divorced 38.66 12.89 21.74 43.48 10.00 15.00 50.00 75.00
 Widowed 58.38 31.57 45.63 64.69 31.31 40.83 22.73 56.36
Socioeconomic status
 Q1 42.67 16.01 22.06 44.47 26.88 35.54 27.39 55.22
 Q2 43.99 16.27 22.92 46.23 26.46 35.46 29.78 60.44
 Q3 41.55 14.90 22.30 46.63 27.54 36.72 27.60 58.40
 Q4 43.39 16.23 23.85 46.46 24.79 34.02 31.46 65.26
Education
 Illiterate 54.40 26.58 35.00 56.10 25.54 32.62 24.83 52.68
 Elementary school 45.43 16.85 22.39 45.08 25.55 34.20 26.19 59.92
 Guidance school 40.87 14.41 20.73 41.93 24.87 34.89 35.83 64.17
 High school 38.02 11.65 16.10 37.15 29.11 41.18 33.15 67.39
 Universities 33.29 8.55 13.65 35.95 30.68 45.38 33.85 60.00
Ethnicity
 Fars 45.63 18.08 24.24 46.05 39.26 52.15 35.64 70.24
 Arab 44.68 15.46 21.47 44.64 13.37 18.58 16.74 45.58
 Bakhtiary 36.79 14.13 24.14 47.68 33.17 43.71 31.65 59.92
 Lor 42.84 17.68 23.28 46.71 50.52 61.00 28.98 59.09
 Others 36.73 8.85 21.69 50.00 5.56 10.00 100.00 100.00
BMI
 Normal (18.6–25) 32.98 9.60 13.31 32.25 28.68 40.65 37.84 68.92
 Underweight (≤18.5) 22.17 4.75 6.04 25.64 36.36 40.00 62.50 87.50
 Overweight (25.1–30) 44.00 16.09 22.09 44.99 25.68 34.46 30.09 60.47
 Obese (>30) 53.00 22.56 29.72 52.60 26.20 34.78 24.23 55.34
Waist-hip ratio (WHR)
 WHR<0.85 27.63 6.29 12.12 38.83 28.47 39.00 37.96 71.30
 0.85≤ WHR <0.9 38.64 11.70 17.24 42.39 25.06 33.66 36.80 69.60
 0.90≤ WHR <0.95 47.33 17.15 21.80 43.74 26.62 36.62 27.47 61.80
 WHR ≥0.95 56.42 26.53 30.81 49.53 26.27 34.76 25.33 53.11
Physical activity
 Insufficient (MET<600/week) 51.81 21.63 24.71 45.49 25.48 33.15 26.70 55.83
 Sufficient (MET ≥ 600/week) 40.76 14.45 22.10 45.93 26.82 36.40 29.59 60.73
Smoking
 No 42.17 15.50 23.27 47.12 27.20 36.55 28.08 59.48
 Current 44.64 14.65 14.96 32.06 18.06 25.69 44.74 65.79
 Former 57.25 27.03 26.75 44.87 20.13 25.42 32.43 56.76
Water pipe (hookah)
 No 42.77 15.94 23.29 46.50 26.16 35.15 29.06 59.59
 Current 42.77 11.99 11.13 28.68 33.33 46.15 20.00 65.00
 Former 47.69 16.70 18.89 42.11 31.71 40.62 33.33 55.56
Family history BP
 No 40.55 13.58 17.17 37.77 25.86 35.10 28.39 60.05
 Yes 46.37 19.22 30.24 54.75 26.75 35.66 29.37 59.31
History of DLP
 No 37.94 12.40 20.67 44.91 22.24 31.32 27.99 61.95
 Yes 47.71 19.18 24.34 46.45 29.13 37.96 29.45 58.40
History of DM
 No 39.74 13.16 17.85 40.15 26.61 35.72 31.38 61.21
 Yes 60.67 30.98 41.02 59.76 25.98 34.93 24.78 56.93
History of CVD
 No 41.57 14.43 19.30 41.62 25.64 34.24 27.14 57.42
 Yes 65.03 39.89 61.63 73.19 28.83 39.58 34.00 65.20
  1. The economic status was defined based on the wealth index, which was calculated by multiple correspondence analysis (MCA) with household’s ownership of selected assets. Physical activity was estimated by metabolic equivalent of task (MET) category, which was calculated based on the international physical activity questionnaire (IPAQ) guideline. Dyslipidaemia was defined as either serum total cholesterol ≥ 200 mg/dL, high-density lipoprotein (HDL) cholesterol <35 mg/dL, or low-density lipoprotein (LDL) cholesterol ≥130 mg/dL or use of lipid-lowering medication. Diabetes Mellitus was defined as fasting plasma glucose levels (FBS) > 126 mg/dL, previously diagnosed DM, or current intake of antidiabetic agents. Cardiovascular diseases was defined if the participant reported any history of myocardial infarction, angiography, or any other related heart diseases.
  2. JNC8 eighth report of the Joint National Committee, ACC/AHA 2017 American College of Cardiology/American Heart Association, BMI body mass index, MET metabolic equivalent of task, DLP dyslipidemia, DM diabetes mellitus, CVD cardiovascular diseases, Q quartile